|
(CRCL) vaccine for Chronic Myelogenous Leukemia
|
5R01CA104926-04
|
$264,158
|
$264,158
|
KATSANIS, EMMANUEL
|
UNIVERSITY OF ARIZONA
|
|
10th International KSHV and Related Agents Workshop
|
1R13CA128447-01
|
$5,000
|
$5,000
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA
|
5R01CA101700-04
|
$356,111
|
$356,111
|
GLICKSON, JERRY
|
UNIVERSITY OF PENNSYLVANIA
|
|
2007 Gordon Research Conference- Cancer and Stem Cells
|
1R13CA130652-01
|
$10,000
|
$5,000
|
CLARKE, MICHAEL
|
STANFORD UNIVERSITY
|
|
28th International Herpesvirus Workshop,
|
5R13CA102553-05
|
$14,223
|
$2,845
|
NELSON, JAY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
A Comprehensive Investigation of Viral-induced Lymphomagenesis
|
5R01CA121180-02
|
$266,661
|
$266,661
|
FISHER, SUSAN
|
UNIVERSITY OF ROCHESTER
|
|
A computer aided chromosome imaging technique for cancer diagnosis
|
5R01CA115320-02
|
$309,600
|
$201,240
|
Liu, Hong
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
A Genome-Wide Association Study of Non-Hodgkin Lymphoma
|
5R01CA122663-02
|
$557,175
|
$557,175
|
Skibola, Christine
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Mediterranean Diet in for Colon Cancer Prevention
|
1R01CA120381-01A1
|
$369,962
|
$369,962
|
DJURIC, ZORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Novel Approach to Nerve-Sparing Prostate Cryosurgery
|
1R43CA128357-01A2
|
$193,904
|
$193,904
|
Snyder, Kristi
|
CELL PRESERVATION SERVICES, INC.
|
|
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
|
5R01CA107300-04
|
$270,281
|
$270,281
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
|
1R01CA129974-01A1
|
$324,900
|
$324,900
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INSTITUTE
|
|
A Phase I Study of Single Agent Flavopiridol in B-Cell *
|
5R21CA119595-02
|
$254,566
|
$254,566
|
LIN, THOMAS
|
OHIO STATE UNIVERSITY
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
2R01CA055577-14
|
$264,061
|
$264,061
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Standardized Nursing Intervention Protocol for HCT Patients
|
5R01CA107446-02
|
$417,565
|
$417,565
|
GRANT, MARCIA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A2a receptor engagement promotes T cell tolerance
|
5R01CA114227-02
|
$254,392
|
$63,598
|
POWELL, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
AbI-Abi signaling in neoplastic hematopoiesis
|
5R01CA094921-06
|
$243,183
|
$243,183
|
DAI, ZONGHAN
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-32S1
|
$215,193
|
$30,127
|
THOMPSON, CRAIG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-32
|
$7,282,327
|
$1,019,526
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
ACSB Central Operations and Data Coodinating Center
|
3U01CA096230-05S1
|
$459,957
|
$285,173
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
$636,008
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of the LMP-1 Protein of Epstein-Barr Virus
|
3R01CA095043-04S1
|
$56,741
|
$28,371
|
MARTIN, JENNIFER
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
Activation of the LMP-1 Protein of Epstein-Barr Virus
|
5R01CA095043-04
|
$231,698
|
$115,849
|
MARTIN, JENNIFER
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
Adenocarcinoma of the Lung: role of NNK susceptibility
|
5R01CA055769-17
|
$642,351
|
$160,588
|
SPITZ, MARGARET
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
3R01CA085915-07S1
|
$51,498
|
$51,498
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
5R01CA085915-07
|
$312,066
|
$312,066
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
1R01CA124782-01A1
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adult Leukemia Research Center
|
2P01CA018029-32
|
$5,086,500
|
$5,086,500
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
AIDS Associated Lymphoproliferative Disorders
|
4R37CA037295-24
|
$402,500
|
$402,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
5U01CA121947-02
|
$5,296,416
|
$3,283,778
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
3R01CA105255-04S1
|
$54,505
|
$54,505
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
5R01CA105255-04
|
$262,919
|
$262,919
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
|
5R01CA128609-02
|
$298,169
|
$298,169
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Allogeneic lymphocyte infusions to treat myeloid cancers
|
5R21CA121588-02
|
$282,657
|
$282,657
|
FUCHS, EPHRAIM
|
JOHNS HOPKINS UNIVERSITY
|
|
Allogeneic T Cell Responses Against Renal Cell Carcinoma
|
5R01CA106512-04
|
$302,644
|
$302,644
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alpha-Particle Immunotherapy of Cancer
|
5R01CA055349-15
|
$389,561
|
$389,561
|
SCHEINBERG, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
ALPHAV INTEGRINS AND TUMOR ANGIOGENESIS
|
5R37CA050286-19
|
$443,508
|
$443,508
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Alternative Entry Mechanism for Pathogenic Retroviruses
|
5R01CA104266-04
|
$259,594
|
$259,594
|
CUNNINGHAM, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
An Ets2 dependent stromal restriction of breast cancer
|
5R01CA098778-05
|
$324,050
|
$324,050
|
OSHIMA, ROBERT
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
|
1R01CA122658-01A2
|
$509,538
|
$127,385
|
KNOBF, M
|
YALE UNIVERSITY
|
|
Analysis of a murine model of the AML1-ETO translocation
|
5R01CA096798-04
|
$281,848
|
$281,848
|
KLUG, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Analysis of CD8 T cell responses to tumors
|
5R01CA071833-10
|
$282,084
|
$282,084
|
DUTTON, RICHARD
|
TRUDEAU INSTITUTE, INC.
|
|
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS
|
5R01CA100933-04
|
$296,523
|
$296,523
|
MITTAL, VIVEK
|
COLD SPRING HARBOR LABORATORY
|
|
Analysis of Intracellular Drug Sequestration
|
5R01CA106655-03
|
$205,489
|
$205,489
|
KRISE, JEFFREY
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Analysis of p53 in vivo using unique mouse model
|
5R01CA100193-05
|
$317,323
|
$158,662
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Analysis of PU.1 Function in Hematopoiesis
|
5R01CA072769-11
|
$291,787
|
$291,787
|
Scott, Edward
|
UNIVERSITY OF FLORIDA
|
|
Analysis of the STAT3 Pathway In Tumor Tolerance and Immune Evasion
|
5R01CA125192-02
|
$282,659
|
$70,665
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
Angiogenesis in Breast Cancer
|
5R01CA106263-03
|
$318,352
|
$143,258
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Angiogenic Factors Associated with Uveal Melanoma
|
5R01CA103653-07
|
$376,608
|
$188,304
|
POLANS, ARTHUR
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Animal Model for Local Inflammation-Induced Breast Cancer
|
1R03CA117486-01A1
|
$75,750
|
$37,875
|
NAKSHATRI, HARIKRISHNA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
Total relevant funding to Hematology for this search: $466,459,388
|